Transient Hypogammaglobulinemia of Infancy

Transient hypogammaglobulinemia of infancy was first described by Gitlin and Janeway in 1956. Transient hypogammaglobulinemia of infancy is a primary immunodeficiency defined as an immunoglobulin deficiency not accompanied by a B cell defect characterized by prolongation of physiological immunoglobulin deficiency. Immunoglobulins may be low in IgA and IgM levels in addition to low IgG levels. It develops after the age of six months as a result of a decrease in IgG antibodies passed to the child through the placenta and insufficient IgG production by the infant. In these cases, IgG levels remain as low as 2 standard deviations in young infants after 6 months of age. Clinically, it can present with very different conditions. It can be completely asymptomatic or present with recurrent infections. Patients with severe disease may be affected by opportunistic infections, atopy or autoimmunity and may have a more complex course, but by definition the disorder must resolve completely. The prognosis of transient hypogammaglobulinemia of infancy depends on the severity of immunodeficiency. In those with symptomatic or mild disease, the prognosis is good and there is no significant morbidity. A small number of patients may present with a condition similar to X-linked agammaglobulinemia and may require lifelong treatment with antimicrobials and intravenous immunoglobulin.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-03-25
DOI
https://doi.org/10.5281/zenodo.15085730
Primary Topic
Immunodeficiency and Autoimmune Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Transient Hypogammaglobulinemia of Infancy

Zenodo (CERN European Organization for Nuclear Research)
Immunodeficiency and Autoimmune Disorders
article

Transient Hypogammaglobulinemia of Infancy

article en

Abstract

Transient hypogammaglobulinemia of infancy was first described by Gitlin and Janeway in 1956. Transient hypogammaglobulinemia of infancy is a primary immunodeficiency defined as an immunoglobulin deficiency not accompanied by a B cell defect characterized by prolongation of physiological immunoglobulin deficiency. Immunoglobulins may be low in IgA and IgM levels in addition to low IgG levels. It develops after the age of six months as a result of a decrease in IgG antibodies passed to the child through the placenta and insufficient IgG production by the infant. In these cases, IgG levels remain as low as 2 standard deviations in young infants after 6 months of age. Clinically, it can present with very different conditions. It can be completely asymptomatic or present with recurrent infections. Patients with severe disease may be affected by opportunistic infections, atopy or autoimmunity and may have a more complex course, but by definition the disorder must resolve completely. The prognosis of transient hypogammaglobulinemia of infancy depends on the severity of immunodeficiency. In those with symptomatic or mild disease, the prognosis is good and there is no significant morbidity. A small number of patients may present with a condition similar to X-linked agammaglobulinemia and may require lifelong treatment with antimicrobials and intravenous immunoglobulin.

Zenodo (CERN European Organization for Nuclear Research)
Sakarya University (TR), Sakarya Eğitim ve Araştırma Hastanesi (TR)
Openalex Percentile: Top 46%
Immunodeficiency and Autoimmune Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.